Follicle dynamics and anovulation in polycystic ovary syndrome.
about
Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competenceGenetic, hormonal and metabolic aspects of PCOS: an updateInsulin signalling and glucose transport in the ovary and ovarian function during the ovarian cycleConvergence of multiple mechanisms of steroid hormone actionNonhuman primate models of polycystic ovary syndromeDisordered follicle developmentThe ovarian reserve of primordial follicles and the dynamic reserve of antral growing follicles: what is the link?Unaltered timing of embryo development in women with polycystic ovarian syndrome (PCOS): a time-lapse study.Oocyte-somatic cell interactions in the human ovary-novel role of bone morphogenetic proteins and growth differentiation factorsScientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.Subcellular redistribution of NHERF1 in response to dehydroepiandrosterone (DHEA) administration in endometrial glands of Wistar ratsGenome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populationsFOXO1/3 depletion in granulosa cells alters follicle growth, death and regulation of pituitary FSH.Association of fibrillin-3 and transcription factor-7-like 2 gene variants with metabolic phenotypes in PCOS.Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.Increased expression of kindlin 2 in luteinized granulosa cells correlates with androgen receptor level in patients with polycystic ovary syndrome having hyperandrogenemia.Minireview: Spatial Programming of G Protein-Coupled Receptor Activity: Decoding Signaling in Health and DiseaseThe characterization of obese polycystic ovary syndrome rat model suitable for exercise interventionSerum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metforminIndustrial endocrine disruptors and polycystic ovary syndrome.Developmental programming: impact of excess prenatal testosterone on intrauterine fetal endocrine milieu and growth in sheep.Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretionDownregulated expression of peroxiredoxin 4 in granulosa cells from polycystic ovary syndrome.Insulin resistance influences central opioid activity in polycystic ovary syndromeExposure of female macaques to Western-style diet with or without chronic T in vivo alters secondary follicle function during encapsulated 3-dimensional cultureOriental medicine Kyung-Ok-Ko prevents and alleviates dehydroepiandrosterone-induced polycystic ovarian syndrome in ratsThe role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment?State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS).The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum.Polycystic ovarian syndrome is accompanied by repression of gene signatures associated with biosynthesis and metabolism of steroids, cholesterol and lipids.Cabergoline plus metformin therapy effects on menstrual irregularity and androgen system in polycystic ovary syndrome women with hyperprolactinemia.Expression and localisation of c-kit and KITL in the adult human ovary.Cell-free DNA in Human Follicular Microenvironment: New Prognostic Biomarker to Predict in vitro Fertilization Outcomes.Developmental programming: prenatal testosterone excess disrupts anti-Müllerian hormone expression in preantral and antral follicles.Crowding and Follicular Fate: Spatial Determinants of Follicular Reserve and Activation of Follicular Growth in the Mammalian Ovary.Ovarian reserve in women of late reproductive age by the method of treatment of PCOS.Correlation of serum Anti-Müllerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle with assisted reproduction outcome in polycystic ovary syndrome patients.Chemokine Ligand 20: A Signal for Leukocyte Recruitment During Human Ovulation?Ontogeny of the ovary in polycystic ovary syndrome.Developmental programming: impact of prenatal testosterone excess on ovarian cell proliferation and apoptotic factors in sheep.
P2860
Q24629523-A009B0E3-5CA5-409B-B872-C066D7C63CB9Q26740034-8956E367-BD93-4DC8-A872-97D7D6216D93Q26745509-EF3628BE-0C34-47D2-ABD9-2D349C4C9968Q26823946-36B3D210-F5DD-4106-8E20-FDA29F1FE064Q26829385-8CB6938E-AF52-4343-9287-97F74530F867Q26851230-45E56491-D2AB-40BA-8B21-B36A4AAEF2B4Q27024729-07A86268-38AD-496D-9886-EBC881591424Q27316069-E5269E7B-B516-4AD1-850D-ABB894C2B75BQ28069613-523DD8FC-CFF7-4B04-A483-6DB264B06500Q28390200-CEEA69F2-E75E-49E2-84B0-C6BC942C22BFQ28570081-88B27000-3C84-492E-8D88-6B59A523CBFBQ30370866-EE586F81-B525-4C5F-A62F-4D46172A8464Q30415092-1864FEEE-5134-49C9-AD81-7D007916C7A2Q30423757-BA28D9A4-9CD9-47B6-8C36-5CFF6987332BQ33569169-E4D9DDB5-3045-4DC7-BF39-326D4C93C1EBQ33593500-9988BFA6-05B1-4ED7-BAB8-C5C46EC69C44Q33631599-8CEDBFE5-ECD7-492C-AE2A-A1457F3959F2Q33721736-53E279AC-D61E-4AD9-96D2-7A509A9A19F8Q34031584-A74ED370-7298-4B1E-BD8F-0708A27AD2D6Q34399051-6AB6B47D-C5CA-4F35-B7C4-508201FD616EQ34450605-81909A31-81AD-4E13-829A-655D81A5A2C7Q34508533-4E01B345-45B2-4030-B58F-19D1C8A46D55Q35009453-68886014-0719-44CA-B15D-956E0573A2FAQ35072207-1A03A089-59F4-476C-94EB-7F5981B11DB7Q35088832-FC5DC080-C7D3-48BD-8A43-1D4DFCC9705BQ35092640-9619DDA1-7A78-44E5-A0D6-FB850716A72DQ35206247-44C86DA5-B17A-406A-81EE-33EE73C8FFD3Q35233754-844FD6D1-A8FA-475B-AB4D-AFCEB9EA8589Q35287911-FC720B97-3A38-489C-96F2-2F7AA67216A1Q35552267-5881983C-780A-428B-A062-B9DE25BFA9BDQ35589236-32747FA8-20CA-4EAF-A00C-B768719870C6Q35700376-F0046F66-EEA5-4E75-9487-CE7181478955Q35750317-30400A72-4519-486D-BCDA-4139394A8CB5Q35798524-6543D469-AF6A-48EC-8F01-418DB7F9FDCDQ35862530-E95DD8B9-FEB9-42ED-B50C-6E2E39338765Q35889590-A337ADB3-45C9-49D9-AC03-C0EA0EBE4111Q35946575-A35635D9-42D6-4809-B0A4-F4789A365A90Q35970931-8B87475D-89CC-4EDB-913B-0C3AA18D18A5Q36035618-86498209-6F19-4069-A842-0F27659EC1E7Q36121632-E81EE49F-A093-46D1-85B8-4F089F913FFE
P2860
Follicle dynamics and anovulation in polycystic ovary syndrome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Follicle dynamics and anovulation in polycystic ovary syndrome.
@en
Follicle dynamics and anovulation in polycystic ovary syndrome.
@nl
type
label
Follicle dynamics and anovulation in polycystic ovary syndrome.
@en
Follicle dynamics and anovulation in polycystic ovary syndrome.
@nl
prefLabel
Follicle dynamics and anovulation in polycystic ovary syndrome.
@en
Follicle dynamics and anovulation in polycystic ovary syndrome.
@nl
P2093
P356
P1476
Follicle dynamics and anovulation in polycystic ovary syndrome.
@en
P2093
Jaroslav Stark
Kate Hardy
Stephen Franks
P304
P356
10.1093/HUMUPD/DMN015
P577
2008-05-22T00:00:00Z